Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma
Clinical trial NCT02999711 · COMPLETED
Trial details
- NCT number
- NCT02999711
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-03
- Primary completion
- 2018-08-30
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.